US 7531523
Sodium channel protein type III alpha-subunit splice variant
granted A61PA61P1/00A61P11/06
Quick answer
US patent 7531523 (Sodium channel protein type III alpha-subunit splice variant) held by Vertex Pharmaceuticals Incorporated expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P1/00, A61P11/06, A61P25/00, A61P25/18